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INTRODUCTION
 
Allergic diseases, including asthma, allergic rhinitis, atopic 
dermatitis, and food and drug allergies cause considerable mor-
bidity and mortality worldwide. As lifestyles and environments 
have changed to become more urbanized and industrialized, 
the incidence and prevalence of allergic diseases has increased, 
and the study of allergy has become one of the most important 
fields in medicine. Allergy remains an important and unsolved 
problem for clinicians and researchers; however, the progressive 
development of immunology, pharmacology, and molecular 
biology has broadened our understanding of the mechanisms 
underlying allergies and has provided us a way to treat patients 
suffering from allergic diseases. 
Although allergology was only recently introduced in Korea, 
Korean allergology has made great progress in keeping pace 
with global scientific advances. The numbers of medical doc-
tors and researchers who investigate allergies and clinical im-
munology have increased and a large amount of scientific prog-
ress has been made. Along with academic progress, allergy and 
clinical immunology has become an indispensable department 
in clinical medicine. Recently, the Korean government recog-
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nized the importance of allergic diseases and began to support 
the prevention and control of allergic diseases. In this article, the 
history of Korean allergology, advances in the research field, and 
various allergy-related activities in Korea are reviewed and the 
future directions of Korean allergology are discussed.
HISTORY OF ALLERGOLOGY IN KOREA
The first professor of allergy and clinical immunology in Korea, 
Dr. Seok-Young Kang, greatly contributed to the introduction of 
allergy studies and laid the foundation of Korean allergology in 
an academically barren land. He founded the Korean Academy 
of Asthma, Allergy, and Clinical Immunology (KAAACI) with 
several researchers and clinicians in 1972 (Fig. 1A). In 1973, the 
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Korean allergology has made great progress in keeping pace with global scientific advances in spite of a short history. Outstanding academic and 
scientific researches have been performed in a variety of allergy fields in Korea. Epidemiologic studies revealed increasing prevalence of asthma 
and allergic diseases and considerable morbidity and mortality in Korea. Novel inhalant allergens such as citrus red mite and two-spotted spider 
mite as causes of asthma and allergic rhinitis have been discovered and reported in Korea. Bidirectional translational researches have been per-
formed and are underway to elucidate the pathogenesis of asthma and allergy, mechanisms of airway inflammation and remodeling, and new ther-
apeutic modalities for asthma and allergic diseases. Experimental asthma models of different phenotypes according to exposed levels of lipopoly-
saccharide or double-stranded RNA suggested the crucial role of the innate immunity in the development of allergic airway inflammation and a new 
insight for asthma pathogenesis, in which both Th1 and Th2 inflammation are involved. In the field of genetic researches, numerous genetic associ-
ations with asthma and asthma-related phenotypes, such as atopy, IgE production, and airway hyperresponsiveness, have been demonstrated in Ko-
rean population. The Easy Asthma Management (EAM) program, a computer-assisted asthma management program, is anticipated to facilitate the 
achievement of more successful clinical outcomes by filling the gaps between guidelines and actual practices. The Integration of these multi-disci-
plinary allergy research resources and translation of scientific achievements to the bedside and society will lead to better allergy and asthma control 
in Korea. 
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first Korean allergy congress was held on the topic of pollen al-
lergies in Seoul. Since then, Korean allergy congresses have been 
held continuously in the spring and autumn biannually (Fig. 1B). 
The first allergy clinic was opened in Seoul National University 
Hospital (SNUH) in 1979 (Fig. 1C) and the allergy division in the 
department of internal medicine at SNUH was launched as an 
independent division for the first time in Korea in 1980. KAAA-
CI joined the Korean Federation of Science and Technology So-
ciety in 1981. 
In the 1980s, the most remarkable achievement of KAAACI 
was the publication of an official journal, “Allergy” (The Journal 
of The Korean Society of Allergology; Fig. 1D). The first edition 
of this journal was published in 1981 with three original articles, 
one case report, four review articles, symposium abstracts, and 
newsletters. Since then, the number of submissions has increas–
ed gradually and articles have encompassed the various allergy 
research fields including epidemiology, occupational allergy, 
animal experiments, molecular biology, and immunology. The 
name of the journal changed to “Journal of Asthma, Allergy and 
Clinical Immunology” in 1998 and continues to be issued quar-
terly. KAAACI and the Korean Academy of Pediatric Allergy & 
Respiratory Disease (KAPARD) jointly inaugurated a new jour-
nal, “Allergy, Asthma & Immunology Research” (AAIR) in Octo-
ber 2009. In addition to this journal, KAAACI has published var-
ious textbooks, including Allergy in 1993, Asthma and Allergic 
Disease in 2002, and various clinical guidebooks (e.g. Korean 
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Fig. 1. Brief view of Korean allergology history. (A) The first general meeting of KAAACI (Foundation meeting: 30 November, 1972). (B) The first Korean allergy con-
gress (8 December, 1973). (C) Professor Seok-Young Kang and early members of the first Allergy Clinic in Korea. (D) (D1) The First Edition of “Allergy” (The Journal of 
The Korean Society of Allergology) issued in June, 1981. (D2) The name of the journal changed to “Journal of Asthma, Allergy and Clinical Immunology” in 1998. (D3) 
The first edition of Asthma, Allergy & Immunologic Research (AAIR), the international journal of KAAA CI and KAPARD in January, 2010. E. The 5th West-Pacific Al-
lergy Symposium (WAPS) and the 7th Korea-Japan Joint Allergy Symposium which was concurrently held with the 25th Anniversary Congress of KAAACI (June, 
1997, Seoul). (F) Organizing committee members of The 5th Asian Pacific Congress of Allergology and Clinical Immunology (APCACI) and the 7th WPAS (October, 
2002, Seoul). (G) The first general meeting of the Korea Asthma Allergy Foundation (KAF) (October, 2003). (H) The second Global Alliance of Chronic Respiratory Dis-
eases (GARD) general meeting and GARD Korea launching in Seoul, Korea (May 2004).Past, Present, and Future of Allergy in Korea
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Asthma Treatment Guideline in 1998, Korean Allergic Rhinitis 
Diagnosis and Treatment Guideline in 1999, and Korean Urti-
caria Treatment Guideline in 2000). 
KAAACI has communicated and had relationships with vari-
ous international allergy societies and has held international 
congresses and joint symposiums successfully since the 1980s. 
KAAACI became the 27th member of the IAACI (WAO) in 1982. 
The first Korea-Japan joint symposium was held in Daegu, Ko-
rea in 1983. Under the leadership of professor Seok-Young Kang 
from Korea and professor Tatsushi Ishizaki from Japan, the first 
West Pacific Allergy Symposium (WPAS) was held in Kwangju, 
Korea in 1986. This symposium was the basis for the foundation 
of the Asia Pacific Association of Allergy, Asthma and Clinical 
Immunology (APAAACI). In 1997, the 5th WPAS and the 7th Ko-
rea-Japan Joint Allergy symposium were held concurrently with 
the 25th Anniversary Congress of the Korean Society of Allergol-
ogy (Fig. 1E). In 2000, the first Interasma North Asia/Korea Chap-
ter was held in Seoul. In 2002, the 5th Asia Pacific Congress of 
Allergology and Clinical Immunology (APCACI) was held con-
currently with the 7th WPAS in Seoul (Fig. 1F). 
In 2003, the Korea Asthma Allergy Foundation (KAF) was laun–
ched to promote the prevention and control of asthma and al-
lergic diseases (Fig. 1G). In 2005, KAF became a founding mem-
ber of Global Alliance of Chronic Respiratory Diseases (GARD). 
In 2007, the second general meeting of GARD was held in Seoul, 
at which time GARD Korea was launched (Fig. 1H). 
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Fig. 2. Growth of Korean allergy SCI papers. These 
data were obtained from a PubMed search (key-
word [allergy or asthma or hypersensitivity] and af-
filiation [Korea])  
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Fig. 3. Prevalence of asthma and allergic diseases based on epidemiologic studies in Korea. (A) Changes in the prevalence of asthma symptoms in Korean school-
aged children between 1995 and 2000. (B) Prevalence of current asthma according to age in Korean adults. (C) Prevalence of perennial allergic rhinitis, (C1) changes 
in prevalence between 1991 and 2001, (C2) prevalence according to age. (D) Prevalence of atopic dermatitis and food allergies based on questionnaires in Korean 
school-aged children.Kim
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ADVANCES IN THE FIELD
Despite a short history, scientific research by Korean allergists 
has expanded quantitatively and qualitatively over the last three 
decades since the publication of the first Korean allergy SCI pa-
per by Kim YY et al.
1 in 1985 (Fig. 2). Currently, many Korean al-
lergy investigators perform global-level scientific research and 
lead innovative projects in various fields of allergy research.
Epidemiology
Prevalence of asthma and allergic diseases 
The prevalence of asthma in Korea has been reported in sev-
eral large-scale studies since the 1990s and ranges from 2% to 
13% according to different methodologies, case definitions, and 
study populations.
2 Nationwide surveys performed in 1995 and 
2000 using the International Study of Asthma and Allergies in 
Childhood (ISAAC) questionnaires showed that the prevalence 
of asthma diagnosis in middle school-aged children (12-15 years 
old) increased from 2.7% in 1995 to 5.3% in 2000 (Fig. 3A).
3 Dur-
ing childhood, body mass index, passive smoking, living with a 
dog or cat, and residence in a large city were associated with a 
higher risk of wheezing.
3 An epidemiologic study based on ques-
tionnaires and methacholine provocation tests in 7- to 19-year-
old subjects in urban cities revealed that the prevalence of asth-
ma was 4.6%.
4 
The prevalence of adult asthma based on the questionnaires 
and methacholine challenge tests increased according to in-
crease of age, and interestingly, asthma prevalence was unex-
pectedly higher in the elderly group (2.0% in <40-year-old, 3.8% 
in 40- to 54-year-old, 7.7% in 55- to 64-year-old, 12.7% in >65- 
year-old; Fig. 3B).
5 The prevalence of perennial allergic rhinitis 
as diagnosed using clinical history and skin test (or MAST, RAST) 
to common inhalant allergen was 3.93%. The highest values (6.02 
%) were observed in teenagers (10- to 19-year-old; Fig. 3C).
6  
The prevalence of atopic dermatitis also increased from 7.3% in 
1995 to 10.7% in 2000 in 6- to 12-year-old and from 3.9% in 1995 
to 6.1% in 2000 in 12- to 15-year-old children (Fig. 3D).
7 
Allergens and occupational allergens in Korea
Based on a nationwide survey, the most common inhalant al-
lergens in Korea include the house dust mite (Dermatophagoi-
des pteronyssinus, Dermatophagoides farinae), Tyrophagus pu-
trescentiae, outdoor spider mites (Tetranychus urticae, Panony-
chus citiri), outdoor molds, indoor molds, cat fur, dog hair, Ger-
man and American cockroaches, tree pollens, mugwort, and 
Japanese hop pollen.
8 Geographical differences were observed 
and the sensitization rates of Japanese cedar pollen and Panon-
ychus citri were especially high in the Jeju province, a southern 
island of Korea.
8
Several important inhalant allergens have been reported in 
Korea. Outdoor spider mites, such as the citrus red mite (CRM; 
P. citiri), European red mite (ERM; P. ulmi), and two-spotted spi-
der mite (TSM; T. urticae), are common allergens among fruit-
cultivating farmers (Fig. 4).
9,10 Specifically, CRMs, first reported 
by Kim YK et al.,
11 are novel and important allergens that cause 
asthma and other allergic diseases among citrus cultivating farm 
and children living in rural areas.
11-13 In addition, outdoor spite 
mites are a common sensitizing allergen associated with asth-
ma and rhinitis symptoms in both rural and urban areas.
14 
Isocyanates including TDI, MDI, and HDI are common occu-
pational allergens in Korea. Park HS et al.,
15-18 identified diisocy-
anate-conjugated protein and demonstrated the pathogenic 
role of specific IgG, as well as specific IgE, and the potential in-
volvement of neutrophils and epithelial cells in TDI-induced 
asthma.
15-18 Reactive dyes,
19,20 herbal dusts such as ginseng and 
sanyak,
21-24 deer hair
25 and shell dust
26 have been reported as 
unique occupational allergens in Korea. 
Asthma burden 
The death rate from chronic lower respiratory diseases includ-
ing asthma between 1992 and 2007 increased from 12.9 (seventh 
leading cause of death) to 15.3 (sixth) deaths per 100,000 peo-
Fig. 4. Outdoor spider mites as novel allergens that cause asthma and allergic 
rhinitis as shown on the cover papers of international allergy journals.
Fig. 5. Mortality rate and leading causes of death in Korea: changes between 
1992 and 2007. 
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ple (Fig. 5). Data from the Korean National Statistical Office and 
National Health Insurance Center (NHIC) suggest a growing 
economic burden of allergic diseases. The cost of asthma was 
estimated at over two billion dollars (the sum of direct and indi-
rect costs) based on NHIC data and National survey on Health 
and Nutrition data in 2004 (Table 1). 
Translational research
Recently, numerous bidirectional translational investigations 
(bench to bedside and bedside to bench) on asthma and aller-
gic diseases have been reported and are underway in Korea. Var-
ious studies using patient samples including blood, sputum, and 
tissue, and animal studies using allergic disease models, trans-
genic mice, and knockout mice are being performed to elucidate 
the pathogenesis of asthma and allergy, mechanisms of airway 
inflammation and remodeling, and new therapeutic modalities 
for asthma and allergy. 
Pathogenesis of asthma and allergy 
Pathologic findings from bronchial biopsy specimens of asth-
matics investigated by Cho SH et al.,
27 revealed that airway in-
flammation and remodeling, such as loss of epithelial cells, in-
filtration of inflammatory cells (especially eosinophil), and in-
creased subepithelial collagen deposition determines the severi-
ty of asthma. This study provides the valuable information that 
airway inflammation and remodeling are major pathologic fea-
tures of asthma and are closely related to asthma severity. 
Park CS et al.,
 investigated the survival and apoptosis of eo-
Table 1. Socioeconomic burden of asthma in Korea (unit: million dollars)
HIRA data NHIC data
Direct cost    573    962
Indirect cost    538 1,086
Intangible cost
*    948 2,066
Direct+Indirect 1,112 2,048
Total 2,059 4,114
HIRA, Health Insurance Review & Assessment Service; NHIC, National Health 
Insurance Cooperation.
*Intangible cost means willingness to pay (WTP) for a month (not a year). WTP 
is usually evaluated higher than true value, but it is unclear how much is app–
ropriate.
Fig. 6. Both Th1 and Th2 inflammation are involved in asthma pathogenesis. (A) 
Different asthma phenotypes according to the co-exposed dose of LPS with 
allergen. (B) Th2 airway inflammation induced by low-dose ds-RNA co-exposure 
with allergen. (C) Th1 airway inflammation induced by high-dose ds-RNA co-
exposure with allergen.
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sinophils isolated from the peripheral blood of atopic patients,
28-30 
and demonstrated that granulocyte macrophage colony-stimu-
lating factor (GM-CSF) plays an important role in eosinophil 
survival in the asthmatic airway.
28 In subsequent studies, the 
cAMP-dependent pathway and Bcl-2 expression were suggest-
ed to be involved in the regulation of eosinophil survival and 
apoptosis.
29,30
Immunologic mechanisms of asthma development 
Various types of asthma animal models expressing the het-
erogenous features of the human asthma phenotype have been 
developed and used for identifying the immunologic mecha-
nism underlying asthma and evaluating the functional role of 
pathogenic molecules.
31-33 Specifically, new animal models that 
are sensitized with allergens and natural environmental adjuvant 
factors via the intranasal route, not the intraperitoneal route, are 
pathophysiologically relevant and show similar characteristics 
to human allergen exposure and sensitization. Experimental 
asthma models of different phenotypes according to exposed 
levels of lipopolysaccharide (LPS) or double-stranded RNA (ds-
RNA) have led to a new paradigm of asthma pathogenesis, in 
which both Th1 and Th2 inflammation are involved.
31,32 These 
results also suggest a crucial role of the innate immune system 
in allergic airway inflammation and immune tolerance break-
down. Furthermore, studies examining mice deficient in toll-like 
receptor (TLR) 3, IL-13, IL-4, signal transducer and activator of 
transcription (STAT) 6, IFN-γ, and T-box expressed in T cells (T-
bet) have elucidated the underlying pathophysiologic mecha-
nisms of allergic lung inflammation development (Th1 and Th2 
inflammation).
32 In these studies, the exposed doses of LPS and 
ds-RNA were an important factor in determining asthma phe-
notype; the high-dose LPS or ds-RNA model showed asthma 
features in which INF-γ and Th1 inflammation were dominant 
(Fig. 6). In fact, cytokine analysis of sputum from non-eosino-
philic severe asthmatics showed enhanced INF-γ mRNA expres-
sion, but not enhanced IL-4 expression.
31 
 
Air pollution and infection in asthma pathogenesis 
The effects of air pollution and respiratory infections on asth-
ma development have also been vigorously investigated. Child-
hood asthma prevalence studies that were performed in the in-
dustrialized urban city Yeocheon showed a higher prevalence 
of current wheezing (18.8%) and airway hyperresponsiveness 
(AHR; 12.2%) in industrial areas compared to residential areas 
(current wheezing, 9.0%; AHR 7.5%).
34 The role of air pollution, 
which has been demonstrated in epidemiologic studies, has also 
been confirmed through in vivo animal studies.
35,36
In a study by Park JK et al., repeated exposure to low-dose sul-
fur dioxide (SO2) in an ovalbumin (OVA)-induced asthma guin-
ea pig model led to enhanced AHR and airway inflammation.
35 
This study indicated that exposure to air pollution, such as SO2, 
may lead to asthmatic reactions by enhancing sensitization to 
allergens. Jang AS et al.,
36 investigated the effects of ozone and 
diesel exhaust particulates (DEP) on asthma development and 
aggravation using an OVA-induced-asthma mouse model and 
found that the OVA-sensitized-challenged mouse exposed to 
ozone and DEP showed higher AHR and IL-4 and lower IFN-γ 
levels in BAL fluid than the control and single exposure groups; 
co-exposure of ozone and DEP was suggested to have an addi-
tive effect on AHR by amplifying airway Th2 inflammation.
36  
LPS, a cell wall component of Gram-negative bacteria, and ds-
RNA, which is produced by many viruses and causes respirato-
ry infection, are frequently encountered molecules in the envi-
ronment. Experiments in asthma animal models using LPS or 
ds-RNA co-exposure with the allergens mentioned above have 
shown that respiratory infection and environmental factors are 
closely related to the development of asthma. In addition, the in-
nate immune system plays a pivotal role in immunologic break-
down during asthma pathogenesis.
31,32 The effects of viral infec-
tion, such as rhinovirus infection and respiratory syncytial virus 
(RSV) infection, on asthma development and exacerbation are 
also under investigation by several Korean researchers. 
New therapeutic modalities for asthma and allergies
New therapeutic modalities through immunologic modula-
tion including CpG oligodeoxynucleotides (CpG-ODNs)
37 and 
recombinant basic fibroblast growth factor 2 (FGF2)
38 have been 
investigated in asthma mouse models. Oligodeoxynucleotides 
containing a CpG motif are considered promising candidates 
for immune modulation in asthma because they are potent in-
ducers of Th1 immunity, enhance the production of IFN-γ from 
OVA-specific T cells, and prevent the development of asthma in 
terms of AHR, airway eosinophilia, and OVA-specific IgE re-
sponses.
37 Therefore, they are anticipated to provide an effective 
method for immune modulation of Th2 allergic asthma. 
Kim YK et al.,
38 evaluated the biological roles of FGF2 in trans-
forming growth factor-beta1 (TGF-β1) over-expressing mice and 
the therapeutic effects of recombinant FGF2 in the development 
of asthma. AHR decreased in TGF-β1 TG (+) mice and was ac-
companied by the up-regulation of FGF2 mRNA expression in 
the lung. However, AHR was markedly enhanced in TGF-β1 (+) 
mice with homozygous FGF2 gene disruption. In this asthma 
mouse model, AHR, mucus production, and lung inflamma-
tion were inhibited markedly by rFGF2 treatment.
38 These data 
suggest that FGF2 is a key inhibitor in the development of AHR, 
and rFGF2 treatment constrains the development of asthma 
phenotypes.
Responsiveness to corticosteroids and the role of TNF-α in Cla-
mydia pneumonia infection was investigated by Cho YS et al.,
39 
C. pneumoniae infection enhanced the proliferation and sur-
vival of immune and inflammatory cells and resulted in steroid 
resistance. These phenomena were reversed by the addition of 
a TNF-α inhibitor. These results suggest that TNF-α may play an 
important role in steroid resistance induced by atypical micro-Past, Present, and Future of Allergy in Korea
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bial respiratory infection. TNF-α inhibitors are therefore a can-
didate agent for managing steroid-resistant severe asthma.
39
The cytoplasmic domain of CTLA-4, a negative regulator of T-
cell activation, shows effective immunosuppressive properties 
that may be of potential use in the treatment of allergic asthma; 
its intranasal administration resulted in markedly reduced infil-
tration of inflammatory cells, secretion of Th2 cytokines, serum 
IgE levels, and AHR in a mouse model of allergic airway inflam-
mation.
40 
Genetic research 
Genetic studies of asthma and allergy susceptibility in Korea 
have been conducted through positional cloning and candidate 
gene association studies.
41 Genome-wide association studies 
are being performed to elucidate genetic factors underlying 
asthma pathogenesis.
42 
Genetic studies for asthma and asthma-related phenotypes
Many genes and genetic polymorphisms associated with asth-
ma and asthma-related phenotypes, such as atopy, IgE produc-
tion, and AHR, were discovered by Korean allergy researchers. 
The genetic association of ADAM33 (disintegrin and metallo-
proteinase domain-containing protein 33 encoding gene), an 
asthma susceptibility gene, was replicated in a Korean popula-
tion.
43 The presence of the ADAM33 protein in bronchoalveolar 
lavage (BAL) fluids of asthmatics is associated with asthma de-
velopment, and ADAM protein levels are related to asthma se-
verity.
44 The TNFA, IL3, IL5RA, CXCR3, PTGER3, PPARG, and 
eotaxin1 genes are also associated with asthma development.
45-51 
IL3, VEGFR2, and FCERIB genes show an association with ato-
py,
46,52,53 and TNFA, RUNX1, and CD40 genes show an associa-
tion with serum IgE production in asthma patients
45,54,55 In addi-
tion, FCERIB, TNFA, and RANTES genes are associated with 
AHR.
56-58 
The combined effects of genes such as TNFA+IL13 and TNFA+ 
CD14 on asthma susceptibility suggest that gene-gene interac-
tions are involved in the pathogenic mechanisms of asthma.
57,59 
Multi-locus analysis using multifactor-dimensionality reduction 
(MDR) has also shown that gene-gene or gene-environmental 
interactions contribute to the development of allergy and asth-
ma.
60,61 
Pharmacogenomic studies 
The realization of personalized and tailored medicine is antic-
ipated in the near future. Pharmacogenomics research will make 
it feasible to predict drug responses and adverse reactions of in-
dividuals. Pharmacogenomic research is mainly performed in 
the field of respiratory therapeutic drugs (bronchodilator, anti-
leukotrienes, theophylline, and corticosteroids) and adverse 
drug reactions (antibiotics, aspirin, allopurinol, and anticonvul-
sant). The B2 adrenergic receptor gene (ADRB2) polymor-
phism is associated with anticholinergics (tiotropium) respons-
es, as well as β2 agonist responses.
62,63 In addition, the TBXA2R 
gene is associated with leukotriene receptor antagonism in Ko-
rean children with asthma.
64 
Genetic associations and gene markers for aspirin intolerance, 
including HLA-DPBI*0301, HLA-DB1*0609, ALOX5, CYSLT, 
PGE2, TBXA2R, and FCER1A were identified in a Korean popu-
lation by Park HS et al.
65 Recently, the genetic interaction of CD40 
and CD40L, which are co-stimulatory danger-signal molecules 
of T cell activation, was reported to be associated with antibiot-
ic-associated cutaneous hypersensitivity reactions.
66 
Clinical studies 
Large-scale, multi-center cohort studies for asthma such as 
COREA (Cohort for Reality and Evolution of adult Asthma),
67 
elderly asthma cohorts, and childhood asthma cohorts have 
been designed since the early 2000s and are ongoing. Many Ko-
rean clinical researchers have participated in various interna-
tional multi-center clinical trials and are involved in the clinical 
application of new drugs, diagnostics, and medical devices. In 
addition to large-scale trials, various types of clinical research, 
including asthma morbidity and patient insight surveys,
2,68 out-
come research, and investigator-initiated trials are being per-
formed. Furthermore, Korean treatment guidelines have been 
developed and revised through systematic review by experts.
69
 
ACTIVITIES OF ALLERGY-RELATED SOCIETIES IN KOREA
Korean Academy of Asthma, Allergy and Clinical Immunology 
The Korean Academy of Asthma, Allergy and Clinical Immu-
nology (KAAACI) was founded in 1972 and consists of physi-
cians, pediatricians, dermatologists, otorhinolaryngologists, 
pathologists, and researchers who are interested in allergy and 
clinical immunology. It started with only 58 members, but now 
it has grown to 1225 members. The main activities of KAAACI 
include research communications (annual allergy congress, re-
search work group, seminars, and symposia), publication of the 
Korean Journal of Allergy, Asthma and Clinical Immunology, 
guideline development, and educational workshops and lec-
tures. In addition, the group has organized international com-
munications such as joint meetings with the World Allergy Con-
gress (WAC), Asia Pacific Congress of Allergy and Clinical im-
munology (APCACI), West Pacific Allergy Symposium (WPAS), 
Interasma, and Korea-Japan Joint Allergy Symposium.  
Korea Asthma Allergy Foundation  
The Korea Asthma Allergy Foundation (KAF) was founded for 
the purpose of supporting academic and research activities, 
public relations, and education related to the prevention of asth-
ma and allergy. In addition, the KAF acts to promote the quality 
of life and health outcomes of patients. The main activities of 
the KAF include public relations (TV, newspaper, and magazine 
campaigns, World Asthma Day ceremony, seminars, and con-Kim
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ventions on asthma/allergic diseases), education (patient edu-
cation, asthma-friendly schools), research (burden of asthma, 
asthma morbidity and patient insight survey, guideline imple-
mentation) and international relationships as an active mem-
ber of GARD. KAF contributed greatly to focussing the govern-
ment’s attention on asthma and allergic diseases, and the orga-
nization developed the nationwide asthma and atopic disease 
prevention and management plan (the Korean government has 
provided three million dollars annually since 2008). 
The development of the Easy Asthma Management (EAM) pro-
gram, a computer-assisted asthma management program, was 
one of the most innovative works of KAF. EAM provides an eas-
ily acceptable, simplified, and practical protocol that focuses  
on the diagnosis, treatment, and monitoring of asthma for gen-
eral practitioners. The use of EAM is anticipated to facilitate the 
achievement of more successful clinical outcomes by filling the 
gaps between guidelines and actual practices.
70,71
  
CONCLUDING REMARKS: PERSPECTIVES OF ALLERGY  
IN KOREA
The research and clinical capacity to understand and treat 
asthma and allergic diseases in Korea were improved remark-
ably in a brief time. Outstanding academic and scientific re-
search has been performed in a variety of allergy research fields, 
including basic immunology, genomics and pharmacogenetics, 
new therapeutic target discovery, and clinical medicine. These 
multi-disciplinary allergy research resources are being integrat-
ed to identify allergic pathogenic mechanisms and curative treat-
ments for allergy. The future directions of allergy research in Ko-
rea will focus on the pathogenic mechanisms of allergy (mech-
anisms of immunologic tolerance breakdown, the impact of the 
environment and climate change, role of extracellular vesicles 
in the development of allergy), the development of new thera-
peutic modalities (discovery of new therapeutic targets and im-
mune modulation), and the realization of personalized medi-
cine. The translation of scientific achievements to the bedside 
and society through the collaboration of researchers and health 
promotion activities will lead to better allergy and asthma con-
trol in Korea.  
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